Skip to main content

A Phase 2, Open-label Study of Encorafenib + Binimetinib in Patients with BRAF V600E-mutant Non-small Cell Lung Cancer

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Array BioPharma Inc

Start Date

June 26, 2019

End Date

December 31, 2024
 

Administered By

Duke Cancer Institute

Awarded By

Array BioPharma Inc

Start Date

June 26, 2019

End Date

December 31, 2024